This approach allowed us to identify more cases of AITL, and more stringent morphological criteria allowed us to identify hallmark cells with strong expression of Ki-1 (CD30), which was essential for differentiating ALK-negative ALCL from CD30+ PTCL-NOS. This evidence concerns the gene TNFRSF8 and angioimmunoblastic T-cell lymphoma.